Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
EvoGenix to Commence Second Project with GlaxoSmithKline
August 31st, 2007
EvoGenix Limited announced that it has entered into a second project with GlaxoSmithKline (GSK) under the terms of a Research and Collaboration Agreement executed between the two companies in October 2005. Successful completion of the first project by EvoGenix was confirmed by GSK and announced in March this year. In the second project EvoGenix will apply its proprietary EvoGene(TM) technology to the optimisation of a further protein selected from the GSK product pipeline. Under the terms of the non-exclusive agreement, EvoGenix receives research funding for up to 3 optimisation projects to be performed for GSK. EvoGenix in return...
Source: Drug Week (2007-08-31)
|
